Remi Gaston-Dreyfus - 09 Jun 2023 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director, 10%+ Owner
Signature
/s/ Remi Gaston-Dreyfus
Issuer symbol
BNKL
Transactions as of
09 Jun 2023
Net transactions value
+$108,333
Form type
4
Filing time
21 Jun 2023, 10:57:15 UTC
Previous filing
21 Jun 2022
Next filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Purchase $108,333 +180,555 +11% $0.6000 1,814,871 09 Jun 2023 Shares held through GD Holdings and Lombard International Assurance SA F1, F2
holding BNKL Common Stock, par value $0.001 per share 61,256 09 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired the shares of common stock in lieu of cash payment of $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.
F2 Includes 17,476 exchangeable shares of the Issuer's subsidiary.